Explore News By Topic

09/08/2017

Prostate Cancer: Owning Your Own Care – Part 3

A three-part series that tells you what you need to know before you go see your doctor. Part I Part II Part III The Proverbial Grain of Salt Treatment and Regrets Don’t Fear Clinical Trials   Part 3: Don’t Fear Clinical Trials Maybe you’re scared to death of a clinical... Read More

09/08/2017

Prostate Cancer: Owning Your Own Care – Part 2

A three-part series that tells you what you need to know before you go see your doctor. Part I Part II Part III The Proverbial Grain of Salt Treatment and Regrets Don’t Fear Clinical Trials   Part 2: Treatment and Regrets Here’s some good news:  A report from the Prostate... Read More

09/08/2017

Prostate Cancer: Owning Your Own Care – Part 1

A three-part series that tells you what you need to know before you go see your doctor. Part I Part II Part III The Proverbial Grain of Salt Treatment and Regrets Don’t Fear Clinical Trials   Part 1:  The Proverbial Grain of Salt In an ideal world, none of this... Read More

07/07/2017

Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer

A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that advanced prostate cancer patients whose tumors have a certain combination of mutations may significantly benefit from treatment with platinum chemotherapy. Not all “chemotherapy” is the same.  Taxane chemotherapy (docetaxel, cabazitaxel) which works... Read More

06/29/2017

Combination of two new therapies may be highly effective in advanced prostate cancer

Early results from a clinical trial presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that combining an immunotherapy with a targeted therapy may be highly effective in patients with advanced prostate cancer. Checkpoint immunotherapy, a treatment that reboots hibernating tumor-killing immune cells, has produced remarkable,... Read More

06/21/2017

Immunotherapy and Prostate Cancer

Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Checkpoint Inhibitors Miracle Drugs for Some, But Not Yet All Checkpoint inhibitors have one mission: to wake up the sleeping T cells, and in some people with cancer, they... Read More

06/20/2017

Immunotherapy: Who’s Who in the Immune System

Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer   Making sense of some very complicated stuff only a few scientists truly understand: A guide to the immune system for the rest of us. Let’s think of the... Read More

06/15/2017

Immunotherapy: A Vaccine for Prostate Cancer

https://youtu.be/h2OFpARcEko   In this three part series, we examine the latest advances in immunotherapy, one of the most promising strategies in cutting edge cancer research, and it's affects on prostate cancer treatment. Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy... Read More

06/09/2017

PCF study finds that adding a 22-gene test to standard prostate cancer risk groups improves accuracy of patient prognosis

A PCF study presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that using a 22-gene test along with standard prostate cancer risk group features vastly improves predictions of how aggressive a patient’s cancer is – enabling clinicians to choose more appropriate therapies and better avoid... Read More

06/07/2017

Cancer patients who self-report symptoms to their doctors on a weekly basis live five months longer

A provocative study at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting reported that metastatic cancer patients who self-reported their symptoms to their doctors on a weekly basis lived 5.2 months longer on average, likely due to more proactive symptom management. Dr. Ethan Basch, a medical oncologist at... Read More